PCOS - Polycystic Ovary Syndrome

PCOS - Polycystic Ovary Syndrome



How does metformin help for PCOS?

Please subscribe to receive our FREE women's health newsletter.
STAY UP TO DATE on the important issues affecting YOUR HEALTH.
First Name:
Family Name:
Email:
Profession:
Country:
Age:
Home
Women's Health Update Blog
Abortion
Amenorrhoea - Absent Periods
Birth Control
Bladder Symptoms
Cancer in Women
Diet / Weight Loss
Dysmenorrhoea
Ectopic Pregnancy
Female Sexual Problems
GUESTBOOK
HRT Risks & Benefits
Hysterectomy
Infections
Infertility
Medication - Drugs
Menopause
Menorrhagia Heavy Periods
Miscarriage
Painful Sex - Dyspareunia
Pap Smear Test
PCOS
Pelvic Pain
PMS- Premenstrual Syndrome
Pregnancy & Childbirth
Vaginal Discharge
Vaginal Prolapse
Viagra, Libido and Sex Drive.
The Author
Consultations
Contact Us

Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):93-8.

Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome. Mitkov M,Pehlivanov B,Terzieva D.

Department of Endocrinology, Medical University, Plovdiv, Bulgaria.

Objectives:

The aim of our study is to investigate and compare the clinical, biochemical and hormonal changes during application of insulin-sensitizers from two different groups.

Study Design:

This prospective, open clinical study lasted 3 months and included 30 women with PCOS, divided in two groups of 15 women each. Group received 850 mg metformin twice a day and group was treated with rosiglitazone 4 mg a day. Serum levels of testosterone, immune reactive insulin (IRI), sex hormone binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS) and lipid metabolism parameters were measured before the treatment, and on the 3rd month. Free androgen index (FAI) and homeostasis model assessment of insulin resistance (HOMA-IR) were calculated. Body mass index (BMI) and waist-to-hip ratio (WHR) were assessed at baseline and at the end of therapy.

Results:

Two parameters change significantly in the 3rd month in our study--testosterone and insulin. Much better decrease in the level of testosterone and free androgen index was established in group treated with metformin, while the indices of insulin resistance were better influenced in the group treated with rosiglitazone.

Conclusion:

Application of insulin sensitizers from both groups has a favorable influence on the basic hormonal deviations in PCOS--the hyperandrogenemia and the insulin resistance. In cases with PCOS metformin treatment influences better hyperandrogenemia, while rosiglitazone affects more pronouncedly insulin resistance and hyperinsulinemia.


Back Home Up Next


See Also:

PCOS - Polycystic Ovary Syndrome

Do you have an unanswered women's health question?

Please let us have your general question on our NEW FORUM / MESSAGE BOARDS facility and we will try to answer it for you. I am sure that you will appreciate that we cannot offer advice on the management of an individual's specific problem.

 

 

Please subscribe to receive our FREE women's health newsletter.
STAY UP TO DATE on the important issues affecting YOUR HEALTH.
First Name:
Family Name:
Email:
Profession:
Country:
Age:
 

DISCLAIMER

The aim of this web site is to provide a general guide and it is not intended as a substitute for a consultation with an appropriate specialist in respect of individual care and treatment.

Thank you for your visiting us at 2womenshealth.com.

This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London.

I do hope that you find the answers to your questions in the patient information and medical advice provided. If you still have unanswered questions, please consider entering them into one of our forums and I will try to assist you.

PCOS - Polycystic Ovary Syndrome